Skip to main content
Journal cover image

Important cellular targets for antimicrobial photodynamic therapy.

Publication ,  Journal Article
Awad, MM; Tovmasyan, A; Craik, JD; Batinic-Haberle, I; Benov, LT
Published in: Appl Microbiol Biotechnol
September 2016

The persistent problem of antibiotic resistance has created a strong demand for new methods for therapy and disinfection. Photodynamic inactivation (PDI) of microbes has demonstrated promising results for eradication of antibiotic-resistant strains. PDI is based on the use of a photosensitive compound (photosensitizer, PS), which upon illumination with visible light generates reactive species capable of damaging and killing microorganisms. Since photogenerated reactive species are short lived, damage is limited to close proximity of the PS. It is reasonable to expect that the larger the number of damaged targets is and the greater their variety is, the higher the efficiency of PDI is and the lower the chances for development of resistance are. Exact molecular mechanisms and specific targets whose damage is essential for microbial inactivation have not been unequivocally established. Two main cellular components, DNA and plasma membrane, are regarded as the most important PDI targets. Using Zn porphyrin-based PSs and Escherichia coli as a model Gram-negative microorganism, we demonstrate that efficient photoinactivation of bacteria can be achieved without detectable DNA modification. Among the cellular components which are modified early during illumination and constitute key PDI targets are cytosolic enzymes, membrane-bound protein complexes, and the plasma membrane. As a result, membrane barrier function is lost, and energy and reducing equivalent production is disrupted, which in turn compromises cell defense mechanisms, thus augmenting the photoinduced oxidative injury. In conclusion, high PDI antimicrobial effectiveness does not necessarily require impairment of a specific critical cellular component and can be achieved by inducing damage to multiple cellular targets.

Duke Scholars

Published In

Appl Microbiol Biotechnol

DOI

EISSN

1432-0614

Publication Date

September 2016

Volume

100

Issue

17

Start / End Page

7679 / 7688

Location

Germany

Related Subject Headings

  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Photochemotherapy
  • Oxidation-Reduction
  • Microbial Viability
  • Metalloporphyrins
  • Light
  • Escherichia coli
  • Drug Resistance, Multiple, Bacterial
  • DNA, Bacterial
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Awad, M. M., Tovmasyan, A., Craik, J. D., Batinic-Haberle, I., & Benov, L. T. (2016). Important cellular targets for antimicrobial photodynamic therapy. Appl Microbiol Biotechnol, 100(17), 7679–7688. https://doi.org/10.1007/s00253-016-7632-3
Awad, Mariam M., Artak Tovmasyan, James D. Craik, Ines Batinic-Haberle, and Ludmil T. Benov. “Important cellular targets for antimicrobial photodynamic therapy.Appl Microbiol Biotechnol 100, no. 17 (September 2016): 7679–88. https://doi.org/10.1007/s00253-016-7632-3.
Awad MM, Tovmasyan A, Craik JD, Batinic-Haberle I, Benov LT. Important cellular targets for antimicrobial photodynamic therapy. Appl Microbiol Biotechnol. 2016 Sep;100(17):7679–88.
Awad, Mariam M., et al. “Important cellular targets for antimicrobial photodynamic therapy.Appl Microbiol Biotechnol, vol. 100, no. 17, Sept. 2016, pp. 7679–88. Pubmed, doi:10.1007/s00253-016-7632-3.
Awad MM, Tovmasyan A, Craik JD, Batinic-Haberle I, Benov LT. Important cellular targets for antimicrobial photodynamic therapy. Appl Microbiol Biotechnol. 2016 Sep;100(17):7679–7688.
Journal cover image

Published In

Appl Microbiol Biotechnol

DOI

EISSN

1432-0614

Publication Date

September 2016

Volume

100

Issue

17

Start / End Page

7679 / 7688

Location

Germany

Related Subject Headings

  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Photochemotherapy
  • Oxidation-Reduction
  • Microbial Viability
  • Metalloporphyrins
  • Light
  • Escherichia coli
  • Drug Resistance, Multiple, Bacterial
  • DNA, Bacterial